(PFNX) |
| 0 (0%) 04-14 17:03 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 01 Oct 2020
Ligand Completes Acquisition of Pfenex Inc. - Business Wire
Mon, 10 Aug 2020
Ligand to Acquire Pfenex Inc. - Business Wire
Mon, 12 Aug 2019
6 Top Gainers In Healthcare Sector (SOLY, PFNX, VRAY…) - RTTNews
Tue, 09 Aug 2016
MESO Gains After Hours, PFNX Gets It Back, CHRS' Humira Biosimilar Meets Goals - RTTNews
Mon, 08 Aug 2016
Pfizer returns rights to Pfenex for Lucentis biosimilar - Fierce Biotech
Fri, 19 Jun 2015
Biosimilar of Novartis' eye drug Lucentis launched in India - Fierce Pharma
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
